Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Creg J Workman

Showing results (11-20 of 83) with videos related to

Pageof 9
Sort By:
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 17, 2021
Interleukin-35: Structure, Function and Its Impact on Immune-Related DiseasesCheng Ye, Hiroshi Yano, Creg J Workman, et al.
Nature Reviews. Cancer|June 10, 2025
Regulatory T cells in the tumour microenvironmentCharlotte J Imianowski, Qiang Chen, Creg J Workman, et al.
Trends in Cancer|November 27, 2024
Advances in LAG3 cancer immunotherapeuticsKieran Adam, Samuel C Butler, Creg J Workman, et al.
Immunology|May 16, 2019
Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunityHiroshi Yano, Lawrence P Andrews, Creg J Workman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223)Nianyu Li, Creg J Workman, Stefani M Martin, et al.
Frontiers in Immunology|June 28, 2021
Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor MicroenvironmentEllen N Scott, Angela M Gocher, Creg J Workman, et al.
Journal for Immunotherapy of Cancer|July 18, 2020
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapyChristopher A Chuckran, Chang Liu, Tullia C Bruno, et al.
Trends in Cancer|July 19, 2022
Therapeutic targeting of regulatory T cells in cancerFeng Shan, Ashwin Somasundaram, Tullia C Bruno, et al.
Seminars in Immunology|October 13, 2019
Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptorElisa Ruffo, Richard C Wu, Tullia C Bruno, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2013
Retraction. Human regulatory T cells require IL-35 to mediate suppression and infectious toleranceVandana Chaturvedi, Lauren W Collison, Clifford S Guy, et al.
Pageof 9

Showing results (11-20 of 83) with videos related to

Sort By:
Pageof 9
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 17, 2021
Interleukin-35: Structure, Function and Its Impact on Immune-Related DiseasesCheng Ye, Hiroshi Yano, Creg J Workman, et al.
Nature Reviews. Cancer|June 10, 2025
Regulatory T cells in the tumour microenvironmentCharlotte J Imianowski, Qiang Chen, Creg J Workman, et al.
Trends in Cancer|November 27, 2024
Advances in LAG3 cancer immunotherapeuticsKieran Adam, Samuel C Butler, Creg J Workman, et al.
Immunology|May 16, 2019
Intratumoral regulatory T cells: markers, subsets and their impact on anti-tumor immunityHiroshi Yano, Lawrence P Andrews, Creg J Workman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 2004
Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223)Nianyu Li, Creg J Workman, Stefani M Martin, et al.
Frontiers in Immunology|June 28, 2021
Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor MicroenvironmentEllen N Scott, Angela M Gocher, Creg J Workman, et al.
Journal for Immunotherapy of Cancer|July 18, 2020
Neuropilin-1: a checkpoint target with unique implications for cancer immunology and immunotherapyChristopher A Chuckran, Chang Liu, Tullia C Bruno, et al.
Trends in Cancer|July 19, 2022
Therapeutic targeting of regulatory T cells in cancerFeng Shan, Ashwin Somasundaram, Tullia C Bruno, et al.
Seminars in Immunology|October 13, 2019
Lymphocyte-activation gene 3 (LAG3): The next immune checkpoint receptorElisa Ruffo, Richard C Wu, Tullia C Bruno, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 6, 2013
Retraction. Human regulatory T cells require IL-35 to mediate suppression and infectious toleranceVandana Chaturvedi, Lauren W Collison, Clifford S Guy, et al.
Pageof 9